Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

PCS2+ Cas9 Citations (4)

Originally described in: Efficient generation of targeted large insertions by microinjection into two-cell-stage mouse embryos.
Gu B, Posfai E, Rossant J Nat Biotechnol. 2018 Jun 11. pii: nbt.4166. doi: 10.1038/nbt.4166.
PubMed Journal

Articles Citing PCS2+ Cas9

Articles
Efficient Generation of Large-Fragment Knock-In Mouse Models Using 2-Cell (2C)-Homologous Recombination (HR)-CRISPR. Gu B, Posfai E, Gertsenstein M, Rossant J. Curr Protoc Mouse Biol. 2020 Mar;10(1):e67. doi: 10.1002/cpmo.67. PubMed
Endogenous protein tagging in medaka using a simplified CRISPR/Cas9 knock-in approach. Seleit A, Aulehla A, Paix A. Elife. 2021 Dec 6;10. pii: 75050. doi: 10.7554/eLife.75050. PubMed

Associated Plasmids

A novel ground truth dataset enables robust 3D nuclear instance segmentation in early mouse embryos. Nunley H, Shao B, Grover P, Singh J, Joyce B, Kim-Yip R, Kohrman A, Watters A, Gal Z, Kickuth A, Chalifoux M, Shvartsman S, Posfai E, Brown L. bioRxiv. 2023 Mar 15:2023.03.14.532646. doi: 10.1101/2023.03.14.532646. Preprint. PubMed
A Window into Mammalian Basement Membrane Development: Insights from the mTurq2-Col4a1 Mouse Model. Jones RA, Trejo B, Sil P, Little KA, Pasolli HA, Joyce B, Posfai E, Devenport D. bioRxiv [Preprint]. 2023 Sep 27:2023.09.27.559396. doi: 10.1101/2023.09.27.559396. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.